Panmedullary edema with inferior olivary hypertrophy in bilateral medial medullary infarction

Yasuteru Inoue1, Fumio Miyashita1, Masatoshi Koga2

  • 1Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.

Insights

Bilateral medial medullary infarction, a rare stroke, can cause inferior olivary nucleus hypertrophy. This case suggests local ischemic damage to the central tegmental tract causes bilateral hypertrophy.

Area of Science:

  • Neurology
  • Neuroscience
  • Stroke Research

Background:

  • Bilateral medial medullary infarction (MMI) is a rare cerebrovascular event associated with significant morbidity.
  • Inferior olivary nucleus hypertrophy is typically linked to lesions within the Guillain-Mollaret triangle.
  • The precise relationship between medial medullary infarction and inferior olivary nucleus hypertrophy remains poorly understood.

Observation:

  • This report details a unique case of acute bilateral medial medullary infarction.
  • The patient presented with subacute bilateral inferior olivary nucleus hypertrophy and panmedullary edema.
  • This presentation is unusual, with only one prior autopsy case of unilateral MMI and ipsilateral hypertrophy documented.

Findings:

  • The study observed bilateral inferior olivary nucleus hypertrophy in conjunction with bilateral medial medullary infarction.
  • The hypertrophy was hypothesized to result from ischemic damage to the central tegmental tract's termination in the inferior olivary nuclei.
  • This finding offers a potential explanation for the observed hypertrophy in the context of MMI.

Implications:

  • This case expands the understanding of the clinical manifestations and potential pathophysiology of medial medullary infarction.
  • It highlights a possible mechanism linking medullary ischemia to specific structural changes in the brainstem.
  • Further research into the Guillain-Mollaret triangle and its response to ischemic events is warranted.

Related Concept Videos

Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Cerebral Edema l: Introduction01:19

Cerebral Edema l: Introduction

Cerebral edema is a pathological increase in brain water content that disrupts intracranial pressure regulation and impairs neurological function. Because the cranial vault is rigid, even modest increases in tissue volume can compromise cerebral perfusion, distort neural structures, and initiate secondary injury. Cerebral edema develops through four principal mechanisms: vasogenic, cytotoxic, interstitial, and ionic.Vasogenic EdemaVasogenic edema arises from disruption of the blood–brain...
Cytotoxic Edema: Pathophysiology01:21

Cytotoxic Edema: Pathophysiology

Cytotoxic edema is a form of cerebral edema characterized by intracellular swelling of neurons, astrocytes, and other glial cells. It develops when the mechanisms responsible for maintaining ionic gradients across the cell membrane become impaired. Under normal physiological conditions, the sodium–potassium ATPase actively transports sodium ions out of the cell and potassium ions into the cell, preserving osmotic balance and enabling electrical signaling. This pump requires a continuous supply...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...